Trial Details

COMPLETED
Basic Information
Clinical ID c3039
Identifier NCT02612649
Trial Title Special Drug Use Surveillance of Irribow in Female Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Diarrhea-predominant Irritable Bowel Syndrome
Interventions DRUG: Ramosetron
Participant Information
Sponsor Astellas Pharma Inc
City Iwate
Country/Region Japan
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2015-10-01
Primary Completion Date 2018-03-31
Completion Date 2018-03-31